Stocks and Investing
Stocks and Investing
Fri, February 26, 2021
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
Tiago Fauth Maintained (APLS) at Hold with Increased Target to $37 on, Feb 26th, 2021
Tiago Fauth of Credit Suisse, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Increased Target from $35 to $37 on, Feb 26th, 2021.
Tiago has made no other calls on APLS in the last 4 months.
There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Tiago
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $104 on, Friday, January 8th, 2021
- Elemer Piros of "Roth Capital" Maintained at Strong Buy with Increased Target to $73 on, Tuesday, December 15th, 2020
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $67 on, Monday, November 23rd, 2020
- Joseph Stringer of "Needham" Initiated at Strong Buy and Held Target at $59 on, Thursday, November 19th, 2020
Contributing Sources